PHIO
Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. insider trading
Insiders at Phio Pharmaceuticals Corp. have been buying its stock on the open market. The largest purchase in the last 30 days was Bradford Patricia A (Director) buying $12.4K of PHIO, filed Sep 16, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $12.4K
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 15, 2026
From SEC filings · last 30 days
Recent PHIO insider transactions
Bradford Patricia ADirector
Bought 12,000 sh at $1.03 · Sep 15, 2026
$12.4K
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
PHIO insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 2 insiders traded PHIO on the open market: 11 purchases worth $59.2K and 0 sales. In the last four quarters alone: 5 purchases ($32.2K) and 0 sales, by one insider.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$9.9K1 buy | — | |
| Q1 2026 | — | — | |
| Q4 2025 | +$22.3K4 buys | — | |
| Q3 2025 | — | — | |
| Q2 2025 | +$27K6 buys | — | |
| Q1 2025 | — | — | |
| Q4 2024 | — | — | |
| Q3 2024 | — | — |
- Largest purchase
- +$9.9K of PHIO by Bitterman Robert J (Chairman, Pres. & CEO · Director) on Jun 26, 2026.
Open-market transactions through Jun 30, 2026most recent first
Bitterman Robert J
Chairman, Pres. & CEO · Director
+$9.9K
Jun 26, 2026
10,000 sh · $0.99
Bitterman Robert J
Chairman, Pres. & CEO · Director
+$5.2K
Dec 31, 2025
5,000 sh · $1.03
Bitterman Robert J
Chairman, Pres. & CEO · Director
+$5.1K
Dec 23, 2025
5,000 sh · $1.02
Bitterman Robert J
Chairman, Pres. & CEO · Director
+$5.7K
Nov 21, 2025
5,000 sh · $1.14
Bitterman Robert J
Chairman, Pres. & CEO · Director
+$6.4K
Nov 18, 2025
5,000 sh · $1.27
Ferrara Robert L
Director
+$6.1K
Jun 10, 2025
2,500 sh · $2.42
Bitterman Robert J
Chairman, Pres & CEO · Director
+$4.8K
Jun 10, 2025
2,000 sh · $2.42
Bitterman Robert J
Chairman, Pres & CEO · Director
+$4.1K
Jun 09, 2025
1,500 sh · $2.75
Bitterman Robert J
Chairman, Pres & CEO · Director
+$2.1K
May 22, 2025
1,200 sh · $1.78
Bitterman Robert J
Chairman, Pres & CEO · Director
+$5.3K
May 21, 2025
3,000 sh · $1.77
Ferrara Robert L
Director
+$4.6K
May 20, 2025
2,500 sh · $1.82
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 26, 2026 | Bitterman Robert JChairman, Pres. & CEO · Director | 10,000 | $0.99 | +$9.9K |
| Dec 31, 2025 | Bitterman Robert JChairman, Pres. & CEO · Director | 5,000 | $1.03 | +$5.2K |
| Dec 23, 2025 | Bitterman Robert JChairman, Pres. & CEO · Director | 5,000 | $1.02 | +$5.1K |
| Nov 21, 2025 | Bitterman Robert JChairman, Pres. & CEO · Director | 5,000 | $1.14 | +$5.7K |
| Nov 18, 2025 | Bitterman Robert JChairman, Pres. & CEO · Director | 5,000 | $1.27 | +$6.4K |
| Jun 10, 2025 | Ferrara Robert LDirector | 2,500 | $2.42 | +$6.1K |
| Jun 10, 2025 | Bitterman Robert JChairman, Pres & CEO · Director | 2,000 | $2.42 | +$4.8K |
| Jun 09, 2025 | Bitterman Robert JChairman, Pres & CEO · Director | 1,500 | $2.75 | +$4.1K |
| May 22, 2025 | Bitterman Robert JChairman, Pres & CEO · Director | 1,200 | $1.78 | +$2.1K |
| May 21, 2025 | Bitterman Robert JChairman, Pres & CEO · Director | 3,000 | $1.77 | +$5.3K |
| May 20, 2025 | Ferrara Robert LDirector | 2,500 | $1.82 | +$4.6K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check PHIO — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Phio Pharmaceuticals Corp. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are PHIO insiders buying or selling?
- Between Sep 15, 2026 and Sep 15, 2026, 1 Phio Pharmaceuticals Corp. insider made 1 open-market purchase worth $12.4K and no sales, a net purchase of $12.4K.
- How much PHIO stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 2 Phio Pharmaceuticals Corp. insiders made 11 open-market purchases worth $59.2K and no sales. In the four quarters to Jun 30, 2026: 5 purchases ($32.2K) and no sales. The largest purchase was Bitterman Robert J buying $9.9K on Jun 26, 2026.
- What was the largest recent PHIO insider trade?
- Bradford Patricia A (Director) bought $12.4K of PHIO stock on Sep 15, 2026 at about $1.03 a share.
- When did an insider last buy PHIO shares?
- The most recent open-market purchase on file is Bradford Patricia A (Director) buying $12.4K on Sep 15, 2026.
- Where does PHIO insider trading data come from?
- From the Form 4 filings Phio Pharmaceuticals Corp.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.